Gajewski, Thomas F.

Glucose Availability Regulates IFN-γ Production and p70S6 Kinase Activation in CD8+ Effector T Cells

Cham, C. M., & Gajewski, T. F. (2005) · The Journal of Immunology

T-cell and B-cell ImmunologyCancer, Hypoxia, and Metabolism

Cited by 359

First-in-human phase I study of the oral inhibitor of indoleamine 2,3-dioxygenase-1 epacadostat (INCB024360) in patients with advanced solid malignancies

Beatty, G. L., O'Dwyer, P. J., Clark, J., Shi, J. G., Bowman, K. J., Scherle, P. A., Newton, R. C., Schaub, R., Maleski, J., Leopold, L., et al. (2017) · Clinical Cancer Research

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 314

Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro

Blank, C., Kuball, J., Voelkl, S., Wiendl, H., Becker, B., Walter, B., Majdic, O., Gajewski, T. F., Theobald, M., Andreesen, R., et al. (2006) · International Journal of Cancer

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 297

Gene Signature in Melanoma Associated With Clinical Activity: A Potential Clue to Unlock Cancer Immunotherapy

Gajewski, T. F., Louahed, J., & Brichard, V. G. (2010) · The Cancer Journal

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 250

Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma

Trujillo, J. A., Luke, J. J., Zha, Y., Segal, J. P., Ritterhouse, L. L., Spranger, S., Matijevich, K., & Gajewski, T. F. (2019) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 159

B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro

Gajewski, T. F. (1996) · The Journal of Immunology

Immunotherapy and Immune ResponsesT-cell and B-cell Immunology

Cited by 114

Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection

Brown, I. E., Blank, C., Kline, J., Kacha, A. K., & Gajewski, T. F. (2006) · The Journal of Immunology

T-cell and B-cell ImmunologyImmunotherapy and Immune Responses

Cited by 91

The Microbiota: A New Variable Impacting Cancer Treatment Outcomes

Fessler, J. L., & Gajewski, T. F. (2017) · Clinical Cancer Research

Gut microbiota and healthCancer Immunotherapy and Biomarkers

Cited by 24